Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
Immunohorizons ; 3(7): 254-261, 2019 07 01.
Article in English | MEDLINE | ID: mdl-31356155

ABSTRACT

The SYK protein-tyrosine kinase is a well-known mediator of signals elicited by the clustering of BCR complexes and other receptors that bear components that contain one or more ITAM sequences. Additional roles for the kinase in signaling through other receptor classes also have been described. To assist in the identification of SYK-regulated processes, we developed mice lacking endogenous Syk genes but containing instead genes coding for an analogue-sensitive form of SYK (SYK-AQL). SYK-AQL supports the development of B cells, and these can be activated with both anti-IgM F(ab')2 through the BCR and LPS through TLR4. An orthogonal inhibitor that selectively targets SYK-AQL blocks the activation of B cells by anti-IgM F(ab')2 in SYK-AQL-expressing but not wild-type cells. The SYK-AQL-specific inhibitor, however, does not block B cell activation in response to LPS in either wild-type or SYK-AQL-expressing cells. Thus, SYK is essential for coupling the BCR but not TLR4 to the activation of B cells.


Subject(s)
B-Lymphocytes/metabolism , Models, Animal , Receptors, Antigen, B-Cell/metabolism , Syk Kinase/genetics , Syk Kinase/metabolism , Toll-Like Receptor 4/metabolism , Alleles , Animals , Antibodies, Anti-Idiotypic/pharmacology , B-Lymphocytes/drug effects , B7-2 Antigen/metabolism , Female , Gene Knock-In Techniques , Immunoreceptor Tyrosine-Based Activation Motif , Lipopolysaccharides/pharmacology , Lymphocyte Activation/drug effects , Male , Mice , Mice, Inbred BALB C , Mice, Inbred C57BL , Mice, Transgenic
2.
Processes (Basel) ; 3(1): 75-97, 2015 Mar.
Article in English | MEDLINE | ID: mdl-26525178

ABSTRACT

The kinase Syk is intricately involved in early signaling events in B cells and is required for proper response when antigens bind to B cell receptors (BCRs). Experiments using an analog-sensitive version of Syk (Syk-AQL) have better elucidated its role, but have not completely characterized its behavior. We present a computational model for BCR signaling, using dynamical systems, which incorporates both wild-type Syk and Syk-AQL. Following the use of sensitivity analysis to identify significant reaction parameters, we screen for parameter vectors that produced graded responses to BCR stimulation as is observed experimentally. We demonstrate qualitative agreement between the model and dose response data for both mutant and wild-type kinases. Analysis of our model suggests that the level of NF-κB activation, which is reduced in Syk-AQL cells relative to wild-type, is more sensitive to small reductions in kinase activity than Erkp activation, which is essentially unchanged. Since this profile of high Erkp and reduced NF-κB is consistent with anergy, this implies that anergy is particularly sensitive to small changes in catalytic activity. Also, under a range of forward and reverse ligand binding rates, our model of Erkp and NF-κB activation displays a dependence on a power law affinity: the ratio of the forward rate to a non-unit power of the reverse rate. This dependence implies that B cells may respond to certain details of binding and unbinding rates for ligands rather than simple affinity alone.

3.
J Biol Chem ; 290(46): 27803-15, 2015 Nov 13.
Article in English | MEDLINE | ID: mdl-26429917

ABSTRACT

Syk is a cytoplasmic kinase that serves multiple functions within the immune system to couple receptors for antigens and antigen-antibody complexes to adaptive and innate immune responses. Recent studies have identified additional roles for the kinase in cancer cells, where its expression can either promote or suppress tumor cell growth, depending on the context. Proteomic analyses of Syk-binding proteins identified several interacting partners also found to be recruited to stress granules. We show here that the treatment of cells with inducers of stress granule formation leads to the recruitment of Syk to these protein-RNA complexes. This recruitment requires the phosphorylation of Syk on tyrosine and results in the phosphorylation of proteins at or near the stress granule. Grb7 is identified as a Syk-binding protein involved in the recruitment of Syk to the stress granule. This recruitment promotes the formation of autophagosomes and the clearance of stress granules from the cell once the stress is relieved, enhancing the ability of cells to survive the stress stimulus.


Subject(s)
Autophagy , Cytoplasmic Granules/enzymology , Intracellular Signaling Peptides and Proteins/metabolism , Protein-Tyrosine Kinases/metabolism , RNA/metabolism , Stress, Physiological , Arsenites/pharmacology , HEK293 Cells , Humans , Intracellular Signaling Peptides and Proteins/genetics , MCF-7 Cells , Phosphorylation , Protein Transport , Protein-Tyrosine Kinases/genetics , Sodium Compounds/pharmacology , Syk Kinase , Tyrosine/genetics , Tyrosine/metabolism
4.
Biochim Biophys Acta ; 1853(1): 254-63, 2015 Jan.
Article in English | MEDLINE | ID: mdl-25447675

ABSTRACT

SYK (spleen tyrosine kinase) is well-characterized in the immune system as an essential enzyme required for signaling through multiple classes of immune recognition receptors. As a modulator of tumorigenesis, SYK has a bit of a schizophrenic reputation, acting in some cells as a tumor promoter and in others as a tumor suppressor. In many hematopoietic malignancies, SYK provides an important survival function and its inhibition or silencing frequently leads to apoptosis. In cancers of non-immune cells, SYK provides a pro-survival signal, but can also suppress tumorigenesis by restricting epithelial-mesenchymal transition, enhancing cell-cell interactions and inhibiting migration.


Subject(s)
Intracellular Signaling Peptides and Proteins/physiology , Protein-Tyrosine Kinases/physiology , Tumor Suppressor Proteins/physiology , Alternative Splicing , Animals , Carcinogenesis , Cell Communication , Cell Survival , Epithelial-Mesenchymal Transition , Humans , Receptors, Antigen, B-Cell/physiology , Signal Transduction/physiology , Syk Kinase
5.
Biochemistry ; 54(1): 60-8, 2015 Jan 13.
Article in English | MEDLINE | ID: mdl-24914616

ABSTRACT

The Syk protein-tyrosine kinase, a well-characterized modulator of immune recognition receptor signaling, also plays important, but poorly characterized, roles in tumor progression, acting as an inhibitor of cellular motility and metastasis in highly invasive cancer cells. Multiharmonic atomic force microscopy (AFM) was used to map nanomechanical properties of live MDA-MB-231 breast cancer cells either lacking or expressing Syk. The expression of Syk dramatically altered the cellular topography, reduced cell height, increased elasticity, increased viscosity, and allowed visualization of a more substantial microtubule network. The microtubules of Syk-expressing cells were more stable to nocodazole-induced depolymerization and were more highly acetylated than those of Syk-deficient cells. Silencing of MAP1B, a major substrate for Syk in MDA-MB-231 cells, attenuated Syk-dependent microtubule stability and reversed much of the effect of Syk on cellular topography, stiffness, and viscosity. This study illustrates the use of multiharmonic AFM both to quantitatively map the local nanomechanical properties of living cells and to identify the underlying mechanisms by which these properties are modulated by signal transduction machinery.


Subject(s)
Breast Neoplasms/metabolism , Intracellular Signaling Peptides and Proteins/metabolism , Microscopy, Atomic Force/methods , Microtubule-Associated Proteins/physiology , Microtubules/metabolism , Nanotechnology/methods , Protein-Tyrosine Kinases/metabolism , Breast Neoplasms/pathology , Cell Line, Tumor , Female , Humans , Microtubules/pathology , Syk Kinase
SELECTION OF CITATIONS
SEARCH DETAIL
...